The common cold: Current therapy and natural history()()()

Despite its prevalence, the common cold is complicated and can be difficult to treat, even symptomatically. There is still no cure for the myriad of viruses that cause the common cold. Many of the most popular remedies are either ineffective or counterproductive. This paper reviews the causes and co...

Descripción completa

Detalles Bibliográficos
Autor principal: Spector, Sheldon L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby, Inc. 1995
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112258/
https://www.ncbi.nlm.nih.gov/pubmed/7751530
http://dx.doi.org/10.1016/S0091-6749(95)70218-0
_version_ 1783513445246697472
author Spector, Sheldon L.
author_facet Spector, Sheldon L.
author_sort Spector, Sheldon L.
collection PubMed
description Despite its prevalence, the common cold is complicated and can be difficult to treat, even symptomatically. There is still no cure for the myriad of viruses that cause the common cold. Many of the most popular remedies are either ineffective or counterproductive. This paper reviews the causes and course of upper respiratory infections, and discusses treatment options, including a new anticholinergic aqueous formulation for controlling rhinorrhea. (J ALLERGY CLIN IMMUNOL 1995;95:1133-8.)
format Online
Article
Text
id pubmed-7112258
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71122582020-04-02 The common cold: Current therapy and natural history()()() Spector, Sheldon L. J Allergy Clin Immunol Article Despite its prevalence, the common cold is complicated and can be difficult to treat, even symptomatically. There is still no cure for the myriad of viruses that cause the common cold. Many of the most popular remedies are either ineffective or counterproductive. This paper reviews the causes and course of upper respiratory infections, and discusses treatment options, including a new anticholinergic aqueous formulation for controlling rhinorrhea. (J ALLERGY CLIN IMMUNOL 1995;95:1133-8.) Mosby, Inc. 1995-05 2005-11-30 /pmc/articles/PMC7112258/ /pubmed/7751530 http://dx.doi.org/10.1016/S0091-6749(95)70218-0 Text en Copyright © 1995 Mosby, Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Spector, Sheldon L.
The common cold: Current therapy and natural history()()()
title The common cold: Current therapy and natural history()()()
title_full The common cold: Current therapy and natural history()()()
title_fullStr The common cold: Current therapy and natural history()()()
title_full_unstemmed The common cold: Current therapy and natural history()()()
title_short The common cold: Current therapy and natural history()()()
title_sort common cold: current therapy and natural history()()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112258/
https://www.ncbi.nlm.nih.gov/pubmed/7751530
http://dx.doi.org/10.1016/S0091-6749(95)70218-0
work_keys_str_mv AT spectorsheldonl thecommoncoldcurrenttherapyandnaturalhistory
AT spectorsheldonl commoncoldcurrenttherapyandnaturalhistory

Ejemplares similares